These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28769539)

  • 1. Elevation of Platelet and Monocyte Activity Markers of Atherosclerosis in Haemodialysis Patients Compared to Peritoneal Dialysis Patients.
    Stach K; Karb S; Akin I; Borggrefe M; Krämer B; Kälsch T; Kälsch AI
    Mediators Inflamm; 2017; 2017():8506072. PubMed ID: 28769539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short- and long-term effects of hemodialysis on platelet and monocyte activity markers of atherosclerosis in patients with end-stage renal disease.
    Benck U; Stach K; Jung S; Krämer BK; Kälsch T; Kälsch AI
    Cardiol J; 2018; 25(5):595-600. PubMed ID: 29240958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of alimentary lipemia and inflammation on platelet CD40-ligand.
    Kälsch T; Elmas E; Nguyen XD; Kralev S; Leweling H; Klüter H; Dempfle CE; Borggrefe M
    Thromb Res; 2007; 120(5):703-8. PubMed ID: 17289125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet and Monocyte Activity Markers and Mortality in Patients with End-Stage Renal Disease.
    Gergei I; Kälsch T; März W; Krämer BK; Kälsch AI
    Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased platelet-monocyte aggregates and cardiovascular disease in end-stage renal failure patients.
    Ashman N; Macey MG; Fan SL; Azam U; Yaqoob MM
    Nephrol Dial Transplant; 2003 Oct; 18(10):2088-96. PubMed ID: 13679485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers.
    Graff J; Harder S; Wahl O; Scheuermann EH; Gossmann J
    Clin Pharmacol Ther; 2005 Nov; 78(5):468-76. PubMed ID: 16321613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endotoxin-induced effects on platelets and monocytes in an in vivo model of inflammation.
    Kälsch T; Elmas E; Nguyen XD; Suvajac N; Klüter H; Borggrefe M; Dempfle CE
    Basic Res Cardiol; 2007 Sep; 102(5):460-6. PubMed ID: 17624488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet and monocyte activity markers and mediators of inflammation in Takotsubo cardiomyopathy.
    Pirzer R; Elmas E; Haghi D; Lippert C; Kralev S; Lang S; Borggrefe M; Kälsch T
    Heart Vessels; 2012 Mar; 27(2):186-92. PubMed ID: 21416113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of CD40 ligand and enhanced monocyte-platelet aggregate formation are associated with worse clinical outcome after ischaemic stroke.
    Lukasik M; Dworacki G; Kufel-Grabowska J; Watala C; Kozubski W
    Thromb Haemost; 2012 Feb; 107(2):346-55. PubMed ID: 22234746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet and monocyte activation in acute ischemic stroke--is there a correlation with stroke etiology?
    Oberheiden T; Nguyen XD; Fatar M; Elmas E; Blahak C; Morper N; Dempfle CE; Hennerici M; Borggrefe M; Kälsch T
    Clin Appl Thromb Hemost; 2012; 18(1):87-91. PubMed ID: 21733938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes.
    Schmidt R; Bültmann A; Fischel S; Gillitzer A; Cullen P; Walch A; Jost P; Ungerer M; Tolley ND; Lindemann S; Gawaz M; Schömig A; May AE
    Circ Res; 2008 Feb; 102(3):302-9. PubMed ID: 18048771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactive leptin resistance and the profile of platelet activation in acute ischaemic stroke patients.
    Lukasik M; Michalak S; Dworacki G; Siewiera K; Kaczmarek M; Watala C; Kozubski W
    Thromb Haemost; 2012 Jul; 108(1):107-18. PubMed ID: 22627503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of the CD40/CD40 ligand dyad and platelet-monocyte aggregation in cigarette smokers.
    Harding SA; Sarma J; Josephs DH; Cruden NL; Din JN; Twomey PJ; Fox KA; Newby DE
    Circulation; 2004 Apr; 109(16):1926-9. PubMed ID: 15078798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of platelets and cellular coagulation in cerebral small-vessel disease.
    Oberheiden T; Blahak C; Nguyen XD; Fatar M; Elmas E; Morper N; Dempfle CE; Bäzner H; Hennerici M; Borggrefe M; Kälsch T
    Blood Coagul Fibrinolysis; 2010 Dec; 21(8):729-35. PubMed ID: 20885295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staphylococcal SSL5-induced platelet microparticles provoke proinflammatory responses via the CD40/TRAF6/NFκB signalling pathway in monocytes.
    Bei JJ; Liu C; Peng S; Liu CH; Zhao WB; Qu XL; Chen Q; Zhou Z; Yu ZP; Peter K; Hu HY
    Thromb Haemost; 2016 Mar; 115(3):632-45. PubMed ID: 26632487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of monocyte-platelet aggregates by imaging flow cytometry.
    Hui H; Fuller K; Erber WN; Linden MD
    Cytometry A; 2015 Mar; 87(3):273-8. PubMed ID: 25514846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newly diagnosed depression is associated with increased beta-thromboglobulin levels and increased expression of platelet activation markers and platelet derived CD40-CD40L.
    Neubauer H; Petrak F; Zahn D; Pepinghege F; Hägele AK; Pirkl PA; Uhl I; Juckel G; Mügge A; Herpertz S
    J Psychiatr Res; 2013 Jul; 47(7):865-71. PubMed ID: 23583028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet activation in patients with peripheral vascular disease: reproducibility and comparability of platelet markers.
    Burdess A; Michelsen AE; Brosstad F; Fox KA; Newby DE; Nimmo AF
    Thromb Res; 2012 Jan; 129(1):50-5. PubMed ID: 21937092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased proatherogenic monocyte-platelet cross-talk in monocyte subpopulations of patients with stable coronary artery disease.
    Czepluch FS; Kuschicke H; Dellas C; Riggert J; Hasenfuss G; Schäfer K
    J Intern Med; 2014 Feb; 275(2):144-54. PubMed ID: 24118494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet CD40 contributes to enhanced monocyte chemoattractant protein 1 levels in patients with resistant hypertension.
    Stumpf C; Raaz D; Klinghammer L; Schneider M; Schmieder RE; Garlichs CD; Achenbach S
    Eur J Clin Invest; 2016 Jun; 46(6):564-71. PubMed ID: 27090943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.